As of Dec 06
| -0.04 / -2.50%|
The 3 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 2.00, with a high estimate of 9.00 and a low estimate of 0.20. The median estimate represents a +28.21% increase from the last price of 1.56.
The current consensus among 5 polled investment analysts is to Hold stock in Evoke Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.